Lufax Granted Extension by NYSE for Filling the 2024 Annual Report on Form 20-F

Rhea-AI Summary

Lufax (NYSE: LU) announced that the New York Stock Exchange granted an extension to file its 2024 annual report on Form 20-F through April 30, 2026, subject to ongoing reassessment.

The company had previously reported a filing delay linked to a proposed auditor change and received NYSE notice of noncompliance with continued listing standards. Lufax has since appointed Ernst & Young and Ernst & Young Hua Ming LLP as auditors and is working with them to finalize and file the 2024 20-F as soon as possible.

If the 20-F is not filed by April 30, 2026, suspension and delisting procedures may commence; the company says it intends to regain compliance within NYSE timelines.

Positive

• NYSE extension through April 30, 2026
• Auditor appointment of Ernst & Young and Ernst & Young Hua Ming LLP
• Company commitment to finalize and file the 2024 20-F promptly

Negative

• NYSE notice of noncompliance with listing standards
• Failure to file by April 30, 2026 could trigger suspension/delisting
• Filing delay caused by auditor change in 2025

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), ("Lufax", or the "Company"), a leading financial services enabler for small business owners in China, today announced that the New York Stock Exchange (the "NYSE") has granted the Company an extension through April 30, 2026 to file the Company's annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "2024 20-F") with the U.S. Securities and Exchange Commission, subject to reassessment on an ongoing basis.

The Company had previously reported that it would be delayed in its filing of the 2024 20-F due to the proposed change in the Company's auditors in 2025 and announced that it had received notice from the NYSE that it was not fully in compliance with the NYSE's continued listing standards. It has since appointed Ernst & Young and Ernst & Young Hua Ming LLP as its auditors. The Company continues to work diligently with its independent auditors to finalize and file the 2024 20-F as soon as possible.

The Company will continue to cooperate with the NYSE in this matter.  If the Company fails to file the 2024 20-F by April 30, 2026, suspension and delisting procedures will commence. The Company intends to regain compliance with the NYSE's continued listing standards by filing the annual report within the NYSE's prescribed timelines.

About Lufax

Lufax is a leading financial services enabler for small business owners in China. Lufax offers financing products designed to address the needs of small business owners and others. In doing so, Lufax has established relationships with 85 financial institutions in China as funding partners, many of which have worked with Lufax for over three years.

Investor Relations Contact

Lufax Holding Ltd
Email: Investor_Relations@lu.com    
ICR, LLC
Robin Yang
Tel: +1 (646) 308-0546
Email: lufax.ir@icrinc.com

View original content:https://www.prnewswire.com/news-releases/lufax-granted-extension-by-nyse-for-filling-the-2024-annual-report-on-form-20-f-302599578.html

SOURCE Lufax Holding Ltd

FAQ

What extension did Lufax (LU) receive from the NYSE to file its 2024 Form 20-F?

The NYSE granted Lufax an extension to file the 2024 Form 20-F through April 30, 2026, subject to reassessment.

Why is Lufax (LU) delayed in filing the 2024 20-F?

Lufax reported the delay was due to a proposed change in the company's auditors in 2025.

Which auditors did Lufax (LU) appoint to complete the 2024 20-F?

Lufax appointed Ernst & Young and Ernst & Young Hua Ming LLP as its auditors.

What happens if Lufax (LU) fails to file the 2024 20-F by April 30, 2026?

If not filed by April 30, 2026, suspension and delisting procedures will commence.

Does Lufax (LU) intend to regain NYSE compliance and file the 2024 20-F?

Yes, the company states it intends to regain compliance by filing the annual report within NYSE timelines.

How is the NYSE extension described in Lufax (LU) disclosures?

The extension is granted subject to ongoing reassessment and continued cooperation with the NYSE.